UBS analyst maintained a Buy rating on Hangzhou Tigermed Consulting Co., Ltd. Class H on May 28 and set a price target of HK$52.00. The company...
Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Hangzhou Tigermed Consulting Co., Ltd. Class H with a €5.95 average price target.
The company has a one-year high of HK$60.60 and a one-year low of HK$29.86. Currently, Hangzhou Tigermed Consulting Co., Ltd. Class H has an average volume of 1.9M.
UBS analyst maintained a Buy rating on China Hongqiao Group Ltd. on May 28 and set a price target of HK$46.10. The company’s…
In a report released on May 28, from UBS maintained a Buy rating on Zhongsheng Group Holdings Ltd., with a price target of…
In a report released on May 28, from UBS maintained a Buy rating on Kanzhun Ltd. Class A, with a price target of HK$89.70. The…
In a report released on May 28, Jacqueline Du from Goldman Sachs maintained a Buy rating on Wuxi Lead Intelligent Equipment Co.,…
In a report released on May 15, from Bank of China maintained a Buy rating on Hua Hong Semiconductor Ltd., with a price target…
In a report released on May 27, from UBS maintained a Buy rating on Bilibili, Inc. Class Z, with a price target of HK$251.16.…
